BAFNAPH BAFNA PHARMACEUTICALS LTD.
Healthcare
LTP
447.9
CHG · %
-9.1 (-1.99%)
VOL · TODAY
7.96K
PREV CLOSE
457
Today's range447.9 · 455
447.9
52-week range94.77 · 479.95
447.9
Loading candles…
Bafna Pharmaceuticals Ltd, incorporated in 1981 and headquartered in Chennai, operates in the pharmaceutical industry. The company manufactures finished pharmaceutical formulations and offers therapeutic products along with Contract Research and Manufacturing Services (CRAMS). Its business segments include finished dosage formulations and CRAMS. Bafna Pharmaceuticals focuses on export markets, serving India and more than 20 countries globally, including both regulated and emerging markets. The company holds global regulatory approvals, notably from the UK-MHRA and TGA Australia.
BAFNAPH is not part of any active scan today.
This page is a live market overview for BAFNA PHARMACEUTICALS LTD. (BAFNAPH) on the BSE. As a listed security, BAFNA PHARMACEUTICALS LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BAFNAPH before placing trades on tick2trade.
As of the latest feed, BAFNAPH last traded at ₹447.9 on BSE, down ₹9.1 (1.99%) from the previous close of ₹457. Today's session range is ₹447.9 – ₹455, against a 52-week band of ₹94.77 – ₹479.95. Traded volume today stands at 7.96K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for BAFNAPH in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BAFNAPH is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BAFNA PHARMACEUTICALS LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BAFNAPH. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BAFNAPH option chain page linked from this overview.
// similar in healthcare326 total